Search alternatives:
larger decrease » marked decrease (Expand Search)
teer decrease » greater decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
larger decrease » marked decrease (Expand Search)
teer decrease » greater decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
2621
-
2622
-
2623
-
2624
-
2625
Presentation 1_Ceftriaxone-associated dysbiosis decreases voriconazole bioavailability by upregulating intestinal P-glycoprotein expression through activation of the Nrf2-mediated...
Published 2025“…The Nrf2 pathway and its related proteins involved in modifying P-glycoprotein (P-gp) expression were clarified by a series of immunoblot analyses.</p>Key findings<p>The diversity and richness of intestinal bacteria, especially the abundance of gram-negative bacteria, were significantly decreased after ceftriaxone treatment. …”
-
2626
Table 1_Ceftriaxone-associated dysbiosis decreases voriconazole bioavailability by upregulating intestinal P-glycoprotein expression through activation of the Nrf2-mediated signall...
Published 2025“…The Nrf2 pathway and its related proteins involved in modifying P-glycoprotein (P-gp) expression were clarified by a series of immunoblot analyses.</p>Key findings<p>The diversity and richness of intestinal bacteria, especially the abundance of gram-negative bacteria, were significantly decreased after ceftriaxone treatment. …”
-
2627
-
2628
-
2629
-
2630
S1 Data -
Published 2024“…AA (OR = 3.016) and CA (OR = 2.130) genotypes were identified as risk factors for stage II. ERCC1 significantly decreased in processing of CWP. The cutoff value of ERCC1 was 5.265 pg/ml, with a sensitivity of 90.0% and specificity of 86.7%. …”
-
2631
Change in the genotypes of <i>ATM</i>, <i>ERCC1</i>, and <i>XRCC1</i>.
Published 2024“…AA (OR = 3.016) and CA (OR = 2.130) genotypes were identified as risk factors for stage II. ERCC1 significantly decreased in processing of CWP. The cutoff value of ERCC1 was 5.265 pg/ml, with a sensitivity of 90.0% and specificity of 86.7%. …”
-
2632
-
2633
-
2634
Data.
Published 2025“…Participants in the progression group were younger (60.7 vs. 65.7 years, P = 0.015) and showed a larger BCVA change (0.20 vs. 0.04, P < 0.001) and greater ERM area decrease (34.2% vs. 11.7%, P < 0.001) during the follow-up period. …”
-
2635
Receiver operating characteristic curve for anti-NIE antibodies for <i>S. stercoralis.</i>
Published 2025“…The seroprevalence increased with age and was significantly decreased following IDA treatment in each age group (<a href="http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0012851#pntd.0012851.g006" target="_blank">Fig 6</a>). …”
-
2636
Table 1_Absolute abundance calculation enhances the significance of microbiome data in antibiotic treatment studies.xlsx
Published 2025“…Here, GCN correction additionally uncovered significant decreases of Lactobacillus and Faecalibacterium. …”
-
2637
Table 3_Absolute abundance calculation enhances the significance of microbiome data in antibiotic treatment studies.xlsx
Published 2025“…Here, GCN correction additionally uncovered significant decreases of Lactobacillus and Faecalibacterium. …”
-
2638
Table 4_Absolute abundance calculation enhances the significance of microbiome data in antibiotic treatment studies.xlsx
Published 2025“…Here, GCN correction additionally uncovered significant decreases of Lactobacillus and Faecalibacterium. …”
-
2639
Table 8_Absolute abundance calculation enhances the significance of microbiome data in antibiotic treatment studies.xlsx
Published 2025“…Here, GCN correction additionally uncovered significant decreases of Lactobacillus and Faecalibacterium. …”
-
2640
Table 2_Absolute abundance calculation enhances the significance of microbiome data in antibiotic treatment studies.xlsx
Published 2025“…Here, GCN correction additionally uncovered significant decreases of Lactobacillus and Faecalibacterium. …”